IDO1 and neoplasm: IDO expression in the TME has been correlated with the induction of multiple tolerogenic immune phenotypes, including the inhibition of effector T cell activation, enhanced infiltration of myeloid-derived suppressor cells, B cell dysfunction, and promotion of tumor angiogenesis [259].